About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer

NCT01084330·36 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Novartis Pharmaceuticals

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Radiologically confirmed advanced gastric cancer
One previous line of chemotherapy
Progressive disease
One measurable lesion
Blood tests within protocol ranges
(WHO) Performance Status ≤ 1
Able to sign informed consent

You may not be if

No symptomatic brain metastases
No coumarin type anticoagulants
No liver or kidney disease
No impaired heart function
No pregnant or lactating women

The record

StatusCompleted

PhasePhase 2

Taking part68

StartedApr 2010

UpdatedDec 10, 2020

Conditions

Advanced Gastric Cancer Gastro-esophageal Junction Cancer

Where36

USC/Kenneth Norris Comprehensive Cancer Center USC/Norris
Los Angeles, California, United States
University of California at Los Angeles Dept. of UCLA (4)
Los Angeles, California, United States
Horizon Oncology Center
Lafayette, Indiana, United States

Clareo Health | Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer